These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31593759)

  • 21. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of in vitro hemolysis and platelet activation of a newly developed maglev LVAD and two clinically used LVADs with human blood.
    Berk ZBK; Zhang J; Chen Z; Tran D; Griffith BP; Wu ZJ
    Artif Organs; 2019 Sep; 43(9):870-879. PubMed ID: 31001834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mathematical model for assessing shear induced bleeding risk.
    Li Y; Wang H; Xi Y; Sun A; Wang L; Deng X; Chen Z; Fan Y
    Comput Methods Programs Biomed; 2023 Apr; 231():107390. PubMed ID: 36745955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
    Feldmann C; Zayat R; Goetzenich A; Aljalloud A; Woelke E; Maas J; Tewarie L; Schmitz-Rode T; Autschbach R; Steinseifer U; Moza A
    PLoS One; 2017; 12(2):e0171029. PubMed ID: 28234916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
    Zhang J; Chen Z; Griffith BP; Wu ZJ
    Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices.
    Geisen U; Brehm K; Trummer G; Berchtold-Herz M; Heilmann C; Beyersdorf F; Schelling J; Schlagenhauf A; Zieger B
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices.
    Tscharre M; Wittmann F; Kitzmantl D; Lee S; Eichelberger B; Wadowski PP; Laufer G; Wiedemann D; Forstner-Bergauer B; Ay C; Panzer S; Zimpfer D; Gremmel T
    Platelets; 2022 Feb; 33(2):249-256. PubMed ID: 33760697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
    Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
    BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
    Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
    J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro study on device-induced damage to blood cellular components and degradation of von Willebrand factor in a CentriMag pump-assisted circulation.
    Wang S; Sun W; Han D; Clark KP; Griffith BP; Wu ZJ
    Artif Organs; 2024 Sep; 48(9):988-996. PubMed ID: 38712632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.
    Coghill PA; Kanchi S; Azartash-Namin ZJ; Long JW; Snyder TA
    ASAIO J; 2019 Jul; 65(5):481-488. PubMed ID: 30004942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.
    Netuka I; Kvasnička T; Kvasnička J; Hrachovinová I; Ivák P; Mareček F; Bílková J; Malíková I; Jančová M; Malý J; Sood P; Sundareswaran KS; Connors JM; Mehra MR
    J Heart Lung Transplant; 2016 Jul; 35(7):860-7. PubMed ID: 27435529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-indicator analysis of mechanical blood damage with five clinical ventricular assist devices.
    Li Y; Wang H; Xi Y; Sun A; Deng X; Chen Z; Fan Y
    Comput Biol Med; 2022 Dec; 151(Pt A):106271. PubMed ID: 36347061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of shear stress on device-induced platelet hemostatic dysfunction relevant to thrombosis and bleeding in mechanically assisted circulation.
    Chen Z; Zhang J; Li T; Tran D; Griffith BP; Wu ZJ
    Artif Organs; 2020 May; 44(5):E201-E213. PubMed ID: 31849074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood trauma potential of the HeartWare Ventricular Assist Device in pediatric patients.
    Granegger M; Thamsen B; Schlöglhofer T; Lach S; Escher A; Haas T; Meboldt M; Schweiger M; Hübler M; Zimpfer D
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1519-1527.e1. PubMed ID: 31444074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired von Willebrand factor deficiency is reduced in HeartMate 3 patients†.
    Klaeske K; Dieterlen MT; Scholz U; Lehmann S; Garbade J; Fischer J; Jawad K; Borger MA; Meyer A
    Eur J Cardiothorac Surg; 2019 Sep; 56(3):444-450. PubMed ID: 30815698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a Rotational Speed Modulation System Used With an Implantable Continuous-Flow Left Ventricular Assist Device on von Willebrand Factor Dynamics.
    Naito N; Mizuno T; Nishimura T; Kishimoto S; Takewa Y; Eura Y; Kokame K; Miyata T; Date K; Umeki A; Ando M; Ono M; Tatsumi E
    Artif Organs; 2016 Sep; 40(9):877-83. PubMed ID: 26750507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.